HealthPartners Begins Clinical Trial For Drug To Treat COVID-19 Pneumonia Patients

Credit: CBS Dallas Digital

Duration: 00:46s 14 Apr 2020 0 shares 1 views

HealthPartners Begins Clinical Trial For Drug To Treat COVID-19 Pneumonia Patients

HealthPartners is now testing a drug which could treat severe COVID-19 pneumonia patients.

Katie Johnston reports.

You might like

Related news coverage

Froedtert to use Remdesivir as treatment after trial data reveals 'drug can block this virus'

Froedtert to use Remdesivir as treatment after trial data reveals 'drug can block this virus'

TODAY’S TMJ4 30 Apr 2020

A breakthrough in the search for a COVID-19 treatment as new data from a clinical trial reveals the positive effects of an..

Data on Gilead drug raises hopes, Fauci calls it 'highly significant'

Data on Gilead drug raises hopes, Fauci calls it 'highly significant'

Reuters Studio

29 Apr 2020

Shares Up On Coronavirus Drug Hopes

Shares Up On Coronavirus Drug Hopes

Wochit

29 Apr 2020

Midmorning With Aundrea - April 29, 2020 (Part 1)

Midmorning With Aundrea - April 29, 2020 (Part 1)

WCBI

28 Apr 2020

New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine

New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine

Wochit Entertainment

27 Apr 2020

Advertisement

More coverage

India begins clinical trial of Convalescent Plasma Therapy for Covid-19, will it work? | Oneindia

India begins clinical trial of Convalescent Plasma Therapy for Covid-19, will it work? | Oneindia

The Drug Controller General of India (DCGI) has approved the clinical trial proposal for convalescent plasma therapy submitted by..

Oneindia 20 Apr 2020

Trial Testing Arthritis Drug Against The Coronavirus Underway In US And Spain

Trial Testing Arthritis Drug Against The Coronavirus Underway In US And Spain

At least six confirmed COVID-19 patients have been enrolled in a clinical trial testing the arthritis drug Actemra. According to..

Wochit News 06 Apr 2020